9 Meters Biopharma Inc (NMTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,960 | -11,606 | -9,230 | -6,778 | -3,988 |
| Depreciation Amortization | 431 | 45 | 32 | 22 | 12 |
| Accounts payable and accrued liabilities | -1,612 | 747 | 1,067 | 564 | 15 |
| Other Working Capital | -2,716 | 49 | 1,030 | 1,078 | 706 |
| Other Operating Activity | 11,890 | 5,669 | 3,935 | 3,060 | 2,433 |
| Operating Cash Flow | $-6,968 | $-5,097 | $-3,165 | $-2,054 | $-822 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14 | -39 | -2 | -2 | -2 |
| Other Investing Activity | 75 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $61 | $-39 | $-2 | $-2 | $-2 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,345 | 5,130 | 4,285 | 1,700 | 575 |
| Common Stock Issued | 18,133 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -1,950 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $19,528 | $5,130 | $4,285 | $1,700 | $575 |
| Beginning Cash Position | 356 | 361 | 361 | 361 | 361 |
| End Cash Position | 12,977 | 356 | 1,479 | 5 | 113 |
| Net Cash Flow | $12,621 | $-5 | $1,118 | $-356 | $-248 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,968 | -5,097 | -3,165 | -2,054 | -822 |
| Capital Expenditure | -14 | -39 | -2 | -2 | -2 |
| Free Cash Flow | -6,981 | -5,135 | -3,167 | -2,056 | -823 |